BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35082207)

  • 21. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer.
    Wu Y; Han Y; Li Q; Zhang P; Yuan P; Luo Y; Fan Y; Chen S; Cai R; Li Q; Xu H; Wang Y; Ma F; Wang J; Xu B
    Breast Cancer Res Treat; 2022 Jun; 193(2):381-392. PubMed ID: 35297009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients.
    Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N
    Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Four Country Study of Strangulation-related Alterations in Consciousness in Women who have Experienced Intimate Partner Violence: Co-occurrence with Traumatic Brain Injuries and Measures of Psychological Distress.
    Adhikari SP; Daugherty JC; Quiroz Molinares N; Maldonado-Rodriguez N; Wallace C; Smirl J; Perez García M; De Los Reyes CJ; Hidalgo-Ruzzante N; van Donkelaar P; Valera E
    J Neurotrauma; 2024 Apr; ():. PubMed ID: 38666734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-Based Breast Cancer Screening Using Digital Breast Tomosynthesis Versus Digital Mammography: Comparison of Screening Performance and Tumor Characteristics.
    Regen-Tuero HC; Ram S; Gass JS; Lourenco AP
    AJR Am J Roentgenol; 2022 Feb; 218(2):249-257. PubMed ID: 34523954
    [No Abstract]   [Full Text] [Related]  

  • 25. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer.
    Wei CT; Tsai IT; Wu CC; Hung WC; Hsuan CF; Yu TH; Hsu CC; Houng JY; Chung FM; Lee YJ; Lu YC
    Int J Med Sci; 2021; 18(12):2689-2696. PubMed ID: 34104101
    [No Abstract]   [Full Text] [Related]  

  • 27. Utility of peripheral blood parameters in predicting breast cancer risk.
    Okuturlar Y; Gunaldi M; Tiken EE; Oztosun B; Inan YO; Ercan T; Tuna S; Kaya AO; Harmankaya O; Kumbasar A
    Asian Pac J Cancer Prev; 2015; 16(6):2409-12. PubMed ID: 25824773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neutrophil/lymphocyte ratio in complete blood count as a mortality predictor in breast cancer].
    Mimica X; Acevedo F; Oddo D; Ibáñez C; Medina L; Kalergis A; Camus M; Sánchez C
    Rev Med Chil; 2016 Jun; 144(6):691-6. PubMed ID: 27598486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mass and the risk of breast cancer: the influence of cumulative exposure to oestrogen and reproductive correlates. Results of the Marburg breast cancer and osteoporosis trial (MABOT).
    Hadji P; Gottschalk M; Ziller V; Kalder M; Jackisch C; Wagner U
    Maturitas; 2007 Mar; 56(3):312-21. PubMed ID: 17049767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taurine, glutamic acid and ethylmalonic acid as important metabolites for detecting human breast cancer based on the targeted metabolomics.
    Wang X; Zhao X; Chou J; Yu J; Yang T; Liu L; Zhang F
    Cancer Biomark; 2018; 23(2):255-268. PubMed ID: 30103303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Adrenal Venous Sampling in Patients with Bilateral Adrenal Masses and ACTH-Independent Cushing's Syndrome.
    Acharya R; Dhir M; Bandi R; Yip L; Challinor S
    World J Surg; 2019 Feb; 43(2):527-533. PubMed ID: 30232569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An analysis of screen-detected invasive cancers by grade in the English breast cancer screening programme: are we failing to detect sufficient small grade 3 cancers?
    Blanks RG; Wallis MG; Alison RJ; Given-Wilson RM
    Eur Radiol; 2021 Apr; 31(4):2548-2558. PubMed ID: 32997179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis.
    Duggan C; Trapani D; Ilbawi AM; Fidarova E; Laversanne M; Curigliano G; Bray F; Anderson BO
    Lancet Oncol; 2021 Nov; 22(11):1632-1642. PubMed ID: 34653370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of cortisol/ACTH ratio (CAR) for diagnosis of cushing's syndrome: comparison of CAR with findings in dexamethasone suppression test.
    Iwamoto Y; Tatsumi F; Itoh T; Sasaki T; Mori S; Sugisaki T; Nakao E; Ohnishi M; Kusano T; Takenouchi H; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Kimura T; Shimoda M; Nakanishi S; Kaku K; Mune T; Kaneto H
    Sci Rep; 2022 Oct; 12(1):17680. PubMed ID: 36271288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of pre-treatment neutrophil: lymphocyte ratio in Japanese patients with breast cancer.
    Nakano K; Hosoda M; Yamamoto M; Yamashita H
    Anticancer Res; 2014 Jul; 34(7):3819-24. PubMed ID: 24982408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
    Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
    Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer.
    Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S
    Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882
    [No Abstract]   [Full Text] [Related]  

  • 40. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Glechner A; Wagner G; Mitus JW; Teufer B; Klerings I; Böck N; Grillich L; Berzaczy D; Helbich TH; Gartlehner G
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009632. PubMed ID: 36999589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.